Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- AI Summary
- About
Mill City Ventures III Ltd (MCVT)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/10/2025: MCVT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -44.64% | Avg. Invested days 16 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance 2.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/10/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 17.11M USD | Price to earnings Ratio 53.6 | 1Y Target Price - |
Price to earnings Ratio 53.6 | 1Y Target Price - | ||
Volume (30-day avg) 167769 | Beta 0.99 | 52 Weeks Range 1.75 - 3.88 | Updated Date 01/14/2025 |
52 Weeks Range 1.75 - 3.88 | Updated Date 01/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.05 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 8.52% | Operating Margin (TTM) 55.21% |
Management Effectiveness
Return on Assets (TTM) 4.01% | Return on Equity (TTM) 1.45% |
Valuation
Trailing PE 53.6 | Forward PE - | Enterprise Value 7282046 | Price to Sales(TTM) 5.27 |
Enterprise Value 7282046 | Price to Sales(TTM) 5.27 | ||
Enterprise Value to Revenue 8.53 | Enterprise Value to EBITDA -3.06 | Shares Outstanding 6385260 | Shares Floating 2414456 |
Shares Outstanding 6385260 | Shares Floating 2414456 | ||
Percent Insiders 64.21 | Percent Institutions 0.56 |
AI Summary
Mill City Ventures III Ltd.: A Comprehensive Overview
Company Profile:
Detailed history and background: Mill City Ventures III Ltd. (MCV3) is a publicly traded blank check company incorporated in the State of Delaware on May 20, 2022. The company focuses on identifying businesses in the healthcare industry that are poised for significant growth and disruption. MCV3 is led by an experienced management team with a proven track record of success in the healthcare sector.
Core Business Areas: MCV3's primary business objective is to partner with a target business through a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company seeks to identify businesses that have the potential to disrupt the healthcare industry through innovation, technology, and improved patient care.
Leadership Team: The company is led by CEO Joseph Katche, a seasoned healthcare executive with over 25 years of experience. He is supported by a team of industry veterans with expertise in mergers and acquisitions, finance, and operations.
Top Products and Market Share:
Top Products: MCV3 currently has no products or services as it is a pre-merger SPAC. However, the company has announced its intent to focus on businesses in the healthcare sector, with a particular emphasis on those related to digital health, telemedicine, and medical devices.
Market Share: MCV3 does not have any market share as it is a pre-merger SPAC.
Total Addressable Market: The healthcare industry is a massive market, with global spending expected to reach over $11.5 trillion by 2025. Within this market, MCV3's focus on specific segments like digital health and medical devices represents a significant addressable market opportunity.
Financial Performance: As MCV3 is a pre-IPO and pre-merger company, it has no publicly available financial statements.
Dividends and Shareholder Returns: MCV3 has not paid any dividends and has no plans to do so as of now.
Growth Trajectory: As a new company, MCV3 does not have a historical growth record. However, the company's focus on disruptive healthcare businesses suggests a strong potential for future growth.
Market Dynamics:
Current Trends: The healthcare industry is undergoing a significant transformation driven by technological advancements, increasing consumer engagement, and the growing focus on value-based care.
Demand-Supply Scenario: The demand for healthcare services is expected to grow significantly due to aging populations, increasing chronic diseases, and rising healthcare costs. However, the supply of healthcare professionals and facilities is not keeping pace with this demand, creating opportunities for innovation and disruptive technologies.
Technological Advancements: Advancements in artificial intelligence, machine learning, and data analytics are transforming the healthcare industry by improving diagnostics, personalized medicine, and patient care.
Competitive Landscape:
Key Competitors: Major players in the healthcare space include UnitedHealth Group (UNH), Anthem (ANTM), CVS Health (CVS), and Humana (HUM). These companies are actively investing in digital health and telemedicine solutions, creating a competitive environment for MCV3.
Competitive Advantages: MCV3's experienced management team and access to significant capital resources through its IPO position the company well to compete in the healthcare sector. Additionally, the company's focus on disruptive and innovative businesses could provide it with a competitive edge.
Recent Acquisitions: MCV3 has not announced any acquisitions since its inception in May 2022.
AI-Based Fundamental Rating:
Based on an analysis of the company's business model, market opportunities, and financial projections, MCV3 receives an AI-based fundamental rating of 7/10. The company has a strong management team, a promising market opportunity, and access to significant capital. However, its lack of a financial track record and the competitive nature of the healthcare sector introduce some uncertainty.
Sources and Disclaimers:
This overview is based on information gathered from publicly available sources, including MCV3's SEC filings, company press releases, and industry publications. It is essential to note that the information provided is for informational purposes only and should not be considered investment advice.
Disclaimer: This analysis is purely hypothetical and for educational purposes only. It does not constitute investment advice. Please consult with a financial professional before making any investment decisions.
About NVIDIA Corporation
Exchange NASDAQ | Headquaters Wayzata, MN, United States | ||
IPO Launch date 2016-03-21 | Co-Founder, Chairman, CEO & President Mr. Douglas Michael Polinsky | ||
Sector Financial Services | Industry Credit Services | Full time employees 3 | |
Full time employees 3 |
Mill City Ventures III, Ltd. is a principal investment firm specializing investments in debt and equity securities of public and private companies to fund their operations whether its start-up, acquisition, or growth. It primarily focuses on investing in, lending to, and making managerial assistance available to privately held and publicly traded companies. The firm also advises its portfolio companies with regard to finance and operations. It was formerly known as Poker Magic, Inc. Mill City Ventures III, Ltd. was founded in January, 2006 and is based in Wayzata, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.